Advances in pharmacological treatment of type 1 diabetes during pregnancy
Sign Up to like & getrecommendations! Published in 2019 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2019.1593372
Abstract: ABSTRACT Introduction: In women with type 1 diabetes mellitus (T1DM), pregnancy is associated with a potential risk of maternal, foetal and neonatal outcomes. Stringent metabolic control is required to improve these outcomes. Areas covered: In… read more here.
Keywords: insulin; pregnancy; control; advances pharmacological ... See more keywords
Advances in the pharmacological management of acute myeloid leukemia in adults
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2022.2111212
Abstract: ABSTRACT Introduction With advances in molecular medicine and precision approaches, there has been significant improvement in the treatment of acute myeloid leukemia (AML) in recent years. This reflects better understanding of molecular and metabolic pathways… read more here.
Keywords: acute myeloid; myeloid leukemia; advances pharmacological; leukemia ... See more keywords
Current advances in the pharmacological prevention and management of cognitive dysfunction in multiple sclerosis
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2022.2161882
Abstract: ABSTRACT Introduction Cognitive impairment (CI) is a core feature of Multiple Sclerosis (MS), being detectable in up to 65% of subjects. Treatment of CI can be considered of paramount importance. However, no standardized strategies are… read more here.
Keywords: advances pharmacological; pharmacological prevention; management; current advances ... See more keywords
Advances in the pharmacological and non-pharmacological management of non-motor symptoms in Parkinson's disease: an update since 2017.
Sign Up to like & getrecommendations! Published in 2022 at "Current neuropharmacology"
DOI: 10.2174/1570159x20666220315163856
Abstract: BACKGROUND Non-motor symptoms (NMS) are an important and ubiquitous determinant of quality of life in Parkinson's disease (PD). However, a robust evidence base for their treatment is still a major unmet need. OBJECTIVE To provide… read more here.
Keywords: pharmacological non; motor symptoms; non motor; parkinson disease ... See more keywords